iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents.
about
iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@en
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@nl
type
label
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@en
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@nl
prefLabel
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@en
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@nl
P2093
P2860
P1476
iGlarLixi, a titratable once-d ...... n with or without oral agents.
@en
P2093
Eric L Johnson
Neil Skolnik
Renell S Dupree
P2860
P304
P356
10.1080/03007995.2017.1359518
P407
P577
2017-07-25T00:00:00Z